金城医药(300233) - 2023 Q1 - 季度财报

| --- | --- | --- | |----------------------------|------------------|------------------| | | | | | 流动负债合计 | 1,620,823,694.48 | 1,700,938,461.45 | | 非流动负债： | | | | 保险合同准备金 | | | | 长期借款 | 345,606,526.52 | 271,690,940.29 | | 应付债券 | | | | 其中：优先股 | | | | 永续债 | | | | | | | | 租赁负债 | 3,287,538.13 | 2,018,994.00 | | 长期应付款 | | | | 长期应付职工薪酬 | | | | 预计负债 | | | | 递延收益 | 63,542,964.32 | 65,995,598.68 | | 递延所得税负债 | 125,976,476.43 | 126,127,539.48 | | 其他非流动负债 | | | | 非流动负债合计 | 538,413,505.40 | 465,833,072.45 | | 负债合计 | 2,1 ...